Search research articles
Contact Us
Filters
Showing results (1411-1420 of 1,490) with videos related to
Page
of 149
Sort By:
Lancet (London, England)
|
January 16, 2010
Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trials
Joseph J Eron, Benjamin Young, David A Cooper, et al.
Indian Journal of Endocrinology and Metabolism
|
November 13, 2025
Study Protocol for Multicentric Hospital-Based Diabetes Registry-Clinical Trial Network
Pramila Kalra, Gurinder Mohan, Prasanta K Bhattacharya, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 21, 2010
Long-term efficacy and safety of Raltegravir combined with optimized background therapy in treatment-experienced patients with drug-resistant HIV infection: week 96 results of the BENCHMRK 1 and 2 Phase III trials
Roy T Steigbigel, David A Cooper, Hedy Teppler, et al.
Journal of Clinical Microbiology
|
December 15, 2017
Zoonotic Transfer of Clostridium difficile Harboring Antimicrobial Resistance between Farm Animals and Humans
C W Knetsch, N Kumar, S C Forster, et al.
Human Genomics
|
June 11, 2023
Systems genetics identifies miRNA-mediated regulation of host response in COVID-19
T Gjorgjieva, A Chaloemtoem, T Shahin, et al.
Journal of Medicinal Chemistry
|
August 19, 2007
Design, synthesis, and evaluation of orally active benzimidazoles and benzoxazoles as vascular endothelial growth factor-2 receptor tyrosine kinase inhibitors
Michele H Potashman, James Bready, Angela Coxon, et al.
Lancet (London, England)
|
June 18, 2026
The UCL-Lancet Commission on Migration and Health: review of the state of progress
Ibrahim Abubakar, David Tellez, Robert W Aldridge, et al.
Antimicrobial Agents and Chemotherapy
|
December 3, 1998
ABT-378, a highly potent inhibitor of the human immunodeficiency virus protease
H L Sham, D J Kempf, A Molla, et al.
Rhinology
|
July 28, 2022
The COVANOS trial - insight into post-COVID olfactory dysfunction and the role of smell training
M Lechner, J Liu, N Counsell, et al.
International Nursing Review
|
August 26, 2016
International study on nurses' views and experiences of compassion
I Papadopoulos, A Zorba, C Koulouglioti, et al.
Page
of 149
Search research articles
Search
Showing results (1411-1420 of 1,490) with videos related to
Sort By:
Page
of 149
Lancet (London, England)
|
January 16, 2010
Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trials
Joseph J Eron, Benjamin Young, David A Cooper, et al.
Indian Journal of Endocrinology and Metabolism
|
November 13, 2025
Study Protocol for Multicentric Hospital-Based Diabetes Registry-Clinical Trial Network
Pramila Kalra, Gurinder Mohan, Prasanta K Bhattacharya, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 21, 2010
Long-term efficacy and safety of Raltegravir combined with optimized background therapy in treatment-experienced patients with drug-resistant HIV infection: week 96 results of the BENCHMRK 1 and 2 Phase III trials
Roy T Steigbigel, David A Cooper, Hedy Teppler, et al.
Journal of Clinical Microbiology
|
December 15, 2017
Zoonotic Transfer of Clostridium difficile Harboring Antimicrobial Resistance between Farm Animals and Humans
C W Knetsch, N Kumar, S C Forster, et al.
Human Genomics
|
June 11, 2023
Systems genetics identifies miRNA-mediated regulation of host response in COVID-19
T Gjorgjieva, A Chaloemtoem, T Shahin, et al.
Journal of Medicinal Chemistry
|
August 19, 2007
Design, synthesis, and evaluation of orally active benzimidazoles and benzoxazoles as vascular endothelial growth factor-2 receptor tyrosine kinase inhibitors
Michele H Potashman, James Bready, Angela Coxon, et al.
Lancet (London, England)
|
June 18, 2026
The UCL-Lancet Commission on Migration and Health: review of the state of progress
Ibrahim Abubakar, David Tellez, Robert W Aldridge, et al.
Antimicrobial Agents and Chemotherapy
|
December 3, 1998
ABT-378, a highly potent inhibitor of the human immunodeficiency virus protease
H L Sham, D J Kempf, A Molla, et al.
Rhinology
|
July 28, 2022
The COVANOS trial - insight into post-COVID olfactory dysfunction and the role of smell training
M Lechner, J Liu, N Counsell, et al.
International Nursing Review
|
August 26, 2016
International study on nurses' views and experiences of compassion
I Papadopoulos, A Zorba, C Koulouglioti, et al.
Page
of 149